| |
| |
|
| Insider
Information: |
Eastbourne Capital Management Llc/ca |
| Relationship: |
10% Owner |
| City: |
San Rafael |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
44,385,290 |
|
|
Indirect Shares
|
48,092,752 |
|
|
| Direct
Value |
$1,036,713,816 |
|
|
|
Indirect Value
|
$579,217,359 |
|
|
| Total
Shares |
92,478,042 |
|
|
| Total
Value |
$1,615,931,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-09-29 |
3,230,204 |
2007-12-31 |
10,901,174 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
11,850,000 |
2010-05-10 |
1,532,709 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2009-09-17 |
13,346,120 |
2007-12-31 |
20,220,126 |
Premium* |
|
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-09-16 |
10,299,755 |
2009-03-11 |
15,438,743 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2010-03-04 |
5,659,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
88 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-10 |
4 |
S |
$5.09 |
$387,703 |
D/D |
(75,838) |
8,714,600 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-09 |
4 |
S |
$5.17 |
$512,282 |
D/D |
(98,969) |
8,790,438 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-08 |
4 |
S |
$5.33 |
$1,531,115 |
D/D |
(286,467) |
8,889,407 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-15 |
4 |
S |
$8.72 |
$19,126,709 |
D/D |
(2,100,000) |
14,900,000 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-02-29 |
4 |
B |
$8.76 |
$131,400 |
D/D |
15,000 |
11,075,874 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-22 |
4 |
B |
$8.89 |
$154,019 |
D/D |
17,325 |
10,968,474 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-02-28 |
4 |
B |
$8.89 |
$222,250 |
D/D |
25,000 |
11,060,874 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-30 |
4 |
B |
$8.95 |
$331,651 |
D/D |
37,056 |
11,025,874 |
2.45 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$8.96 |
$41,278,295 |
D/D |
(4,600,245) |
10,299,755 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-02-22 |
4 |
B |
$8.98 |
$89,800 |
D/D |
10,000 |
11,035,874 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-29 |
4 |
B |
$9.03 |
$183,706 |
D/D |
20,344 |
10,988,818 |
2.45 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-14 |
4 |
S |
$9.10 |
$13,719,925 |
D/D |
(1,500,000) |
17,000,000 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-17 |
4 |
B |
$9.49 |
$282,594 |
D/D |
29,700 |
10,951,149 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-16 |
4 |
B |
$9.53 |
$2,621 |
D/D |
275 |
10,921,449 |
2.37 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-15 |
4 |
B |
$9.63 |
$82,337 |
D/D |
8,550 |
10,921,174 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2008-01-14 |
4 |
B |
$9.75 |
$111,638 |
D/D |
11,450 |
10,912,624 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2009-09-17 |
4 |
S |
$13.89 |
$20,124,372 |
D/D |
(1,443,241) |
13,346,120 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$14.09 |
$34,088,489 |
D/D |
(2,410,639) |
14,789,361 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-08-27 |
4 |
S |
$20.07 |
$128,143,018 |
D/D |
(6,026,562) |
17,200,000 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-03-17 |
4 |
B |
$24.50 |
$742,742 |
D/D |
30,316 |
20,325,442 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-02-29 |
4 |
B |
$26.45 |
$1,333,198 |
D/D |
50,000 |
20,295,126 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-02-28 |
4 |
B |
$27.40 |
$685,000 |
D/D |
25,000 |
20,245,126 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-30 |
4 |
B |
$27.72 |
$9,886,393 |
D/D |
356,652 |
22,826,562 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-05-07 |
4 |
B |
$27.88 |
$6,976,615 |
D/D |
250,000 |
23,076,562 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-03-26 |
4 |
B |
$28.03 |
$1,152,661 |
D/D |
41,067 |
20,456,509 |
2.45 |
- |
|
88 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
